Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ziprasidone in Pediatric Bipolar I Disorder
NCT02075047Phase 3Terminated
- Sponsor
- Viatris
- Start
- May 2014
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of ziprasidone in bipolar I disorder, sponsored by Viatris. Started May 2014; status: terminated.
02
Drugs
ziprasidone
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT02075047.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02075047.